Anemia: Clinical Trials

37 trials for Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 unknown. 37 Phase 1, 21 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 137Unknown 37
Phase 221Unknown 21

Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects
MY008211A tablets, Placebo - Paroxysmal Nocturnal Hemoglobinuria
Phase 1UnknownWuhan Createrna Science and Technology Co., Ltd162024-08-102024-08-09
NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major
n-acetylcystine - Thalassemia Major
Phase 1UnknownAssiut University1002024-03-232023-08-23
Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors
Sirolimus, Abatacept, MMF - Acute Leukemia, Myelodysplastic Syndromes
Phase 1 / Phase 2UnknownPeking University People's Hospital62024-03-012024-03-21
CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy
ThisCART19A - Autoimmune Hemolytic Anemia, CD19 CAR-T Cell Infusion
Phase 1UnknownInstitute of Hematology & Blood Diseases Hospital, China132024-01-202024-03-22
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
umbilical cord derived mesenchymal stem cells - Hematologic Neoplasms, Neutropenia
Phase 1 / Phase 2UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1812023-01-012023-01-05
Autologous Tregs for Aplastic Anaemia
Expanded autologous T regulatory cells - Aplastic Anemia
Phase 1UnknownKing's College Hospital NHS Trust122022-07-142023-10-05
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
CD62L- Tem - Lymphoma, Leukemia
Phase 1UnknownUniversity College, London182019-10-212019-10-25
Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO
Inhaled Nitric Oxide, Placebo - Anemia
Phase 1 / Phase 2UnknownNew York Medical College502019-02-062019-04-24
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
Lactoferrin, Recombinant human erythropoietin - Anemia
Phase 1UnknownCyprus University of Technology502019-01-142022-09-06
Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia
autologous umbilical cord blood (UCB), standard care - Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal
Phase 1UnknownMononuclear Therapeutics Ltd.402018-04-162018-06-07
Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With Simvastatin
Simvastatin 40mg - Sickle Cell Disease, Stroke
Phase 1 / Phase 2UnknownUniversity of Campinas, Brazil282018-03-052020-10-12
Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
Autologous CD34+ cells genetically modified - Beta Thalassemia Major
Phase 1 / Phase 2UnknownNanfang Hospital, Southern Medical University102017-09-152017-09-08
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia
mesenchymal stem cells - Aplastic Anemia
Phase 1UnknownHebei Medical University102017-01-012017-04-07
Limiting Chemotherapy Side Effects by Using Moxa
Moxibustion - Breast Neoplasms, Colorectal Neoplasms
Phase 1 / Phase 2UnknownEast and North Hertfordshire NHS Trust252016-02-012016-05-24
Gene Therapy for Transfusion Dependent Beta-thalassemia
Autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene - Beta-Thalassemia
Phase 1 / Phase 2UnknownIRCCS San Raffaele102015-05-012019-06-28
Dose-Escalation Study of SCD-101 in Sickle Cell Disease
SCD-101 - Sickle Cell Disease, Sickle-Beta Zero Thalassemia
Phase 1UnknownInvenux, LLC602015-02-012023-03-21
Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Rabbit antithymoglobulin (ATG), Adipose derived mesenchymal stem cells ( AD-MSCs), AD-MSC transdifferentiated HSCs (AD-HSCs) - Severe Aplastic Anemia
Phase 1 / Phase 2UnknownNavy General Hospital, Beijing902015-01-012015-04-03
Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes
Pegol-sihematide injection - Myelodysplastic Syndromes, Anemia
Phase 1UnknownJiangsu Hansoh Pharmaceutical Co., Ltd.242014-06-012015-12-02
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
Peripheral blood stem cell mobilisation and collection, High-dose chemotherapy, Bone marrow derived allogeneic MMSCs infusion - Neutropenic Enterocolitis, Myeloablative Chemotherapy Induced Bone Marrow Aplasia
Phase 1 / Phase 2UnknownBurnasyan Federal Medical Biophysical Center162014-05-012015-06-10
Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
allogeneic donor derived B-lymphocytes - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1 / Phase 2UnknownUniversity of Erlangen-Nürnberg Medical School152013-11-012014-03-26

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Anemia, Aplastic (15)  ·  Anemia, Sickle Cell (8)  ·  Myelodysplastic Syndromes (5)  ·  Anemia, Neonatal (3)  ·  Hematologic Diseases (3)  ·  Lymphoma (3)  ·  beta-Thalassemia (3)  ·  Enterocolitis, Necrotizing (2)  ·  Fanconi Anemia (2)  ·  Graft vs Host Disease (2)  ·  Hodgkin Disease (2)  ·  Leukemia (2)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Leukemia, Myeloid, Acute (2)

Broader conditions

Hemic and Lymphatic Diseases (37)  ·  Hematologic Diseases (34)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (18)  ·  Bone Marrow Diseases (17)  ·  Genetic Diseases, Inborn (15)  ·  Anemia, Hemolytic (14)  ·  Bone Marrow Failure Disorders (14)  ·  Anemia, Hemolytic, Congenital (12)  ·  Hemoglobinopathies (11)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Pathologic Processes (8)  ·  Immune System Diseases (7)  ·  Cardiovascular Diseases (6)  ·  Digestive System Diseases (5)

Interventions

Sirolimus (2)  ·  Abatacept (1)  ·  Alemtuzumab (1)  ·  Amifostine (1)  ·  Busulfan (1)  ·  Citrulline (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Deferasirox (1)  ·  Deferoxamine (1)  ·  Drug Therapy (1)  ·  Ferric Oxide, Saccharated (1)  ·  Filgrastim (1)  ·  Folic Acid (1)  ·  Lactoferrin (1)

Sponsors

Federal University of Bahia (2)  ·  Angiogenix (1)  ·  Assiut University (1)  ·  Burnasyan Federal Medical Biophysical Center (1)  ·  Cyprus University of Technology (1)  ·  Dana-Farber Cancer Institute (1)  ·  Diane George (1)  ·  East and North Hertfordshire NHS Trust (1)  ·  GAAD Medical Research Institute Inc. (1)  ·  Guangzhou General Hospital of Guangzhou Military Command (1)  ·  Hainan Medical College (1)  ·  Hebei Medical University (1)  ·  IRCCS San Raffaele (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Invenux, LLC (1)

Countries

China (10)  ·  United States (7)  ·  United Kingdom (4)  ·  Germany (2)  ·  Poland (2)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Cyprus (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Nigeria (1)  ·  Russia (1)  ·  South Korea (1)

Top investigators

A O Dosunmu, M.D. (1)  ·  Alessandro Aiuti, MD, PhD (1)  ·  Baoyong Yan, Doctor (1)  ·  Beverley A de Valois, PhD (1)  ·  Bing Ma, Master (1)  ·  Boguslaw Machalinski, MD, PhD, BSc (1)  ·  Bojian Sun, Master (1)  ·  Bruno Benites, MD (1)  ·  Dan Zhao, Master (1)  ·  Demao Yang, PhD (1)  ·  Diane George, MD (1)  ·  Edmund LaGamma, MD (1)  ·  Fabio Ciceri, MD (1)  ·  Fan Zhang, Bachelor (1)

Results publications

PMID 18191732, PMID 22818551, PMID 22875626, PMID 23731760, PMID 25104129, PMID 25927273, PMID 26021713, PMID 26340878, PMID 26643677, PMID 28096387, PMID 29788942, PMID 29906796, PMID 38467031, PMID 41742894

NIH funding

2014 (1), U54RR019397 (1)